When tackling LGMD, researchers expanded the target group of LGMD2C/SGCG [92] and explored the mutations in LGMD2A/CAPN3 [159], LGMD2G/TCAP [160], and LGMD2B/DYSF [161]. The gene discussed is TCAP; the disease is limb-girdle muscular dystrophy.